Cargando…

Persistent Extended-Spectrum β-Lactamase Urinary Tract Infection

Detalles Bibliográficos
Autores principales:	DeBusscher, Joan, Zhang, Lixin, Buxton, Miatta, Foxman, Betsy, Barbosa-Cesnik, Cibele
Formato:	Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2009
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857214/ https://www.ncbi.nlm.nih.gov/pubmed/19891891 http://dx.doi.org/10.3201/eid1511.081501

Ejemplares similares

Extended spectrum beta-lactamase urinary tract infections
por: Aboumarzouk, Omar M.
Publicado: (2014)

Prevalence of extended-spectrum β-lactamase positive bacteria in radiologically positive urinary tract infection
por: Masud, Md Rana, et al.
Publicado: (2014)

Complicated urinary tract infection caused by extended spectrum β-lactamase-producing Escherichia coli
por: Ranjan, K. P., et al.
Publicado: (2014)

Persistent infection with metallo-beta-lactamase and extended spectrum β-lactamase producer Morganella morganii in a patient with urinary tract infection after kidney transplantation
por: Leylabadlo, Hamed Ebrahimzadeh, et al.
Publicado: (2016)

Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
por: Cho, Sung-Yeon, et al.
Publicado: (2016)

A clinical prediction tool for extended-spectrum β-lactamase-producing Enterobacteriaceae urinary tract infection
por: Liu, Hui, et al.
Publicado: (2022)

Efficacy of Noncarbapenem β-Lactams Compared to Carbapenems for Extended-Spectrum β-Lactamase–Producing Enterobacterales Urinary Tract Infections
por: Anderson, Daniel T, et al.
Publicado: (2022)

Extended-spectrum β-lactamase-producing enterobacteriaceae in community-acquired urinary tract infections in São Luís, Brazil
por: Abreu, Afonso Gomes, et al.
Publicado: (2013)

Outcome of Antimicrobial Therapy of Pediatric Urinary Tract Infections Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae
por: Lee, Bongjin, et al.
Publicado: (2013)

Extended-Spectrum β-Lactamases among Enterobacteriaceae Isolated from Urinary Tract Infections in Gaza Strip, Palestine
por: Tayh, Ghassan, et al.
Publicado: (2019)

Extended-spectrum beta-lactamase Escherichia coli and Klebsiella pneumoniae urinary tract infections
por: Vachvanichsanong, P., et al.
Publicado: (2020)

Antimicrobial Susceptibilities of Urinary Extended-spectrum β-lactamase Escherichia coli to Fosfomycin
por: Saeed, Nermin Kamal, et al.
Publicado: (2021)

Emergence of Multidrug Resistant Extended-Spectrum β-Lactamase Producing Eshcherichia coli Associated With Urinary Tract Infections in Bangladesh
por: Mowla, Rumana, et al.
Publicado: (2011)

Molecular characterization of extended spectrum β -lactamases enterobacteriaceae causing lower urinary tract infection among pediatric population
por: Eltai, Nahla O., et al.
Publicado: (2018)

Risk Factors for Community Acquired Extended-Spectrum Β-lactamase (ESBL) Producing Enterobacteriaceae Urinary Tract Infections (UTIs)
por: Goyal, Dheeraj, et al.
Publicado: (2017)

Impact of an antimicrobial stewardship program on urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
por: Esteve-Palau, Erika, et al.
Publicado: (2018)

Risk factors for community-onset urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli
por: TÜZÜN, Türkan, et al.
Publicado: (2019)

2261. Oral Fosfomycin for Treatment of Urinary Tract Infections Due to Extended-Spectrum β-Lactamase and Carbapenem-Resistant Enterobacteriaceae
por: Hefler, Jade L, et al.
Publicado: (2019)

Combining Microarray Technology and Molecular Epidemiology to Identify Genes Associated with Invasive Group B Streptococcus
por: Zhang, Lixin, et al.
Publicado: (2008)

Frequency of antimicrobial resistance among invasive and colonizing Group B Streptococcal isolates
por: Borchardt, Stephanie M, et al.
Publicado: (2006)

Treatment duration of complicated urinary tract infections by extended-spectrum beta-lactamases producing enterobacterales
por: Álvarez Otero, Judith, et al.
Publicado: (2020)

Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae
por: Han, Seung Beom, et al.
Publicado: (2015)

Assessment of Factors Associated With Community-Acquired Extended-Spectrum β-Lactamase–Producing Escherichia coli Urinary Tract Infections in France
por: Paumier, Adeline, et al.
Publicado: (2022)

Antimicrobial susceptibility and integrons detection among extended-spectrum β-lactamase producing Enterobacteriaceae isolates in patients with urinary tract infection
por: Abubaker, Karzan Taha, et al.
Publicado: (2023)

Phenotypic characterization and epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae strains from urinary tract infections in Garoua, Cameroon
por: Djim-Adjim-Ngana, Karyom, et al.
Publicado: (2023)

Community Transmission of Extended-Spectrum β-Lactamase
por: Mirelis, Beatriz, et al.
Publicado: (2003)

Prevalence and Risk Factors for Extended Spectrum Beta-Lactamase-Producing Uropathogens in Patients with Urinary Tract Infection
por: Lee, Dong Sup, et al.
Publicado: (2010)

Multidrug resistance and extended-spectrum β-lactamases genes among Escherichia coli from patients with urinary tract infections in Northwestern Libya
por: Abujnah, Abubaker A., et al.
Publicado: (2015)

Characterization of Hypervirulent Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae Among Urinary Tract Infections: The First Report from Iran
por: Taraghian, Azadeh, et al.
Publicado: (2020)

1472. Non-Carbapenems for Treating Community-Associated Urinary Tract Infection Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Children
por: Joo Jung, Hyun, et al.
Publicado: (2019)

477. Characterization of Extended-Spectrum Β-Lactamase (ESBL) Producing Gram-negative (GN) Urinary Tract Infections (UTI) in Pediatric Patients
por: Stach, Leslie, et al.
Publicado: (2019)

Metallo-β-Lactamase and Extended-Spectrum-β-Lactamase Production by Serratia Strains [Letter]
por: Singh, Bhoj R, et al.
Publicado: (2020)

Extended-spectrum ß-Lactamase-producing Enterobacteriaceae as a Common Cause of Urinary Tract Infections in Sri Lanka
por: Tillekeratne, L. Gayani, et al.
Publicado: (2016)

Experience with fosfomycin in the treatment of complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae
por: Bielen, Luka, et al.
Publicado: (2019)

Novel Extended-spectrum β-Lactamase in Shigella sonnei
por: Lefort, Agnes, et al.
Publicado: (2007)

Extended-spectrum β-lactamases in Gram Negative Bacteria
por: Rawat, Deepti, et al.
Publicado: (2010)

In Silico Analysis of Extended-Spectrum β-Lactamases in Bacteria
por: Mlynarcik, Patrik, et al.
Publicado: (2021)

Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunities
por: Husna, Asmaul, et al.
Publicado: (2023)

Antimicrobial susceptibility pattern of extended-spectrum β-lactamase-producing bacteria causing nosocomial urinary tract infections in an Iranian referral teaching hospital
por: Soltani, Rasool, et al.
Publicado: (2014)

Fosfomycin, interesting alternative drug for treatment of urinary tract infections created by multiple drug resistant and extended spectrum β-lactamase producing strains
por: Yeganeh-Sefidan, Fatemeh, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_r8mqr6d5nqmiqtfle5h9bh85rg